These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 27330038

  • 21. Molecular identification and antifungal susceptibility profiles of clinical strains of Fonsecaea spp. isolated from patients with chromoblastomycosis in Rio de Janeiro, Brazil.
    Coelho RA, Brito-Santos F, Figueiredo-Carvalho MHG, Silva JVDS, Gutierrez-Galhardo MC, do Valle ACF, Zancopé-Oliveira RM, Trilles L, Meyer W, Freitas DFS, Almeida-Paes R.
    PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006675. PubMed ID: 30048450
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Photodynamic therapy combined with terbinafine against chromoblastomycosis and the effect of PDT on Fonsecaea monophora in vitro.
    Hu Y, Huang X, Lu S, Hamblin MR, Mylonakis E, Zhang J, Xi L.
    Mycopathologia; 2015 Feb; 179(1-2):103-9. PubMed ID: 25366276
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Case Report: A Case of Chromoblastomycosis Caused by Fonsecaea pedrosoi in Vietnam.
    Le TA, Nguyen KL, Pham MH, Vi TT, Do NA.
    Mycopathologia; 2019 Feb; 184(1):115-119. PubMed ID: 29974323
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Synergistic effect of terbinafine and amphotericin B in killing Fonsecaea nubica in vitro and in vivo.
    Zhang J, Wu X, Li M, Huang J, Yin S, Huang H, Lu C, Xi L.
    Rev Inst Med Trop Sao Paulo; 2019 Jun 19; 61():e31. PubMed ID: 31241660
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. New Molecular Markers Distinguishing Fonsecaea Agents of Chromoblastomycosis.
    Schneider GX, Gomes RR, Bombassaro A, Zamarchi K, Voidaleski MF, Costa FF, Leão ACR, Lima BJFS, Soley BS, Colombo IR, Cândido GZ, Najafzadeh MJ, Sun J, de Azevedo CMPS, Marques SG, de Hoog GS, Vicente VA.
    Mycopathologia; 2019 Aug 19; 184(4):493-504. PubMed ID: 31317385
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment.
    Queiroz-Telles F, Esterre P, Perez-Blanco M, Vitale RG, Salgado CG, Bonifaz A.
    Med Mycol; 2009 Feb 19; 47(1):3-15. PubMed ID: 19085206
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Endemic Chromoblastomycosis Caused Predominantly by Fonsecaea nubica, Madagascar1.
    Rasamoelina T, Maubon D, Andrianarison M, Ranaivo I, Sendrasoa F, Rakotozandrindrainy N, Rakotomalala FA, Bailly S, Rakotonirina B, Andriantsimahavandy A, Rabenja FR, Andrianarivelo MR, Cornet M, Ramarozatovo LS.
    Emerg Infect Dis; 2020 Jun 19; 26(6):1201-1211. PubMed ID: 32441639
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.